| ISIN | CH0004015290 |
|---|---|
| Valor Number | 401529 |
| Bloomberg Global ID | SYNSWST SW |
| Fund Name | SYNCHRONY MARKET FUNDS - Synchrony Swiss Equity A |
| Fund Provider |
Banque Cantonale de Genève
Genève, Switzerland Phone: +41 58 211 21 11 E-Mail: info@bcge.ch Web: www.bcge.ch |
| Fund Provider | Banque Cantonale de Genève |
| Representative in Switzerland | |
| Distributor(s) |
Banque Cantonale Vaudoise Lausanne Phone: +41 21 212 10 00 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Distribution |
| Home Country | Switzerland |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The objective of the Synchrony Swiss Equity Subfund is long term capital growth by investing in shares of the Swiss companies that make up the SPI® index. Companies are identified and selected based on their fundamentals, using a systematic stock-picking methodology. The Subfund invests at least two-thirds of its assets in shares and other securities or participation rights of companies domiciled or having a predominant amount of their business activity in Switzerland, and which are part of the SPI® index. |
| Peculiarities |
| Current Price * | 107.61 CHF | 12.12.2025 |
|---|---|---|
| Previous Price * | 107.79 CHF | 11.12.2025 |
| 52 Week High * | 108.73 CHF | 03.03.2025 |
| 52 Week Low * | 90.92 CHF | 09.04.2025 |
| NAV * | 107.61 CHF | 12.12.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 201,317,992 | |
| Unit/Share Assets *** | 58,376,201 | |
| Trading Information SIX | ||
| YTD Performance | +9.09% |
31.12.2024 - 12.12.2025
31.12.2024 12.12.2025 |
|---|---|---|
| 1 month | +0.30% |
12.11.2025 - 12.12.2025
12.11.2025 12.12.2025 |
| 3 months | +3.32% |
12.09.2025 - 12.12.2025
12.09.2025 12.12.2025 |
| 6 months | +1.60% |
12.06.2025 - 12.12.2025
12.06.2025 12.12.2025 |
| 1 year | +7.82% |
12.12.2024 - 12.12.2025
12.12.2024 12.12.2025 |
| 2 years | +14.59% |
12.12.2023 - 12.12.2025
12.12.2023 12.12.2025 |
| 3 years | +17.19% |
12.12.2022 - 12.12.2025
12.12.2022 12.12.2025 |
| 5 years | +23.55% |
14.12.2020 - 12.12.2025
14.12.2020 12.12.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Nestle SA | 11.40% | |
|---|---|---|
| Novartis AG Registered Shares | 11.22% | |
| Roche Holding AG | 9.98% | |
| UBS Group AG Registered Shares | 6.91% | |
| ABB Ltd | 6.60% | |
| Zurich Insurance Group AG | 5.40% | |
| Lonza Group Ltd | 3.69% | |
| Compagnie Financiere Richemont SA Class A | 3.46% | |
| Sika AG | 2.86% | |
| Givaudan SA | 2.77% | |
| Last data update | 31.08.2025 | |
| TER | 0.77% |
|---|---|
| TER date | 15.09.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.00% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | 30.11.2025 |